Abstract
BackgroundAlthough tumour necrosis factor-alpha inhibitor (TNFi) therapy has proven efficacy in the management of psoriatic arthritis (PsA), relatively little is known about predictors of TNFi persistence. Such knowledge would assist...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have